Shopping Cart 0
Cart Subtotal
AED 0

Intermountain Healthcare Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

Intermountain Healthcare Inc (Intermountain Healthcare) is a non-profit health care system. It provides health care services to Utah and Southeastern Idaho residents. It offers a wide range of clinical programs covering cardiovascular, intensive medicine, primary care, pediatric specialties, surgical services, behavioral health, neurosciences, and musculoskeletal and its clinical services cover dialysis, environmental, food and nutrition, clinical genetics institute, imaging, integrated care management, laboratory, nursing, pain, patient and provider publications, patient flow, patient safety, pharmacy, rehabilitation, and respiratory care. Intermountain Healthcare operates through hospitals and clinics at various locations including Burley, Smithfield, Tremonton, Logan, Providence, Brigham City, Heber City, among several others. Intermountain is headquartered in Salt Lake City, Utah, the US.

Intermountain Healthcare Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Intermountain Healthcare Inc, Medical Devices Deals, 2012 to YTD 2018 10

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

Tute Genomics Raises Additional USD3.9 Million in Series A1 Venture Financing 12

Ingram Medical Raises USD 30 Million In Series B Venture Financing 13

Partnerships 14

Seven Hospitals and Three Philanthropic Foundations Form Civica RX 14

Intermountain Healthcare Enters into Agreement with Stanford Genome Technology Center 16

Intermountain Healthcare Inc-Key Competitors 17

Intermountain Healthcare Inc-Key Employees 18

Intermountain Healthcare Inc-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Joint Venture 21

Recent Developments 22

Strategy And Business Planning 22

Sep 20, 2018: New Intermountain Transformation Center to Lead Healthcare Delivery Advancement 22

Sep 06, 2018: Not-for-profit generic drug company officially established, attracts interest of more than 120 health organizations 23

Mar 01, 2018: Intermountain Healthcare Launches New Company, Expanding Access to Proven Mental Health Integration Approach 24

Corporate Communications 25

Aug 09, 2018: Intermountain Healthcare Names New Leaders to Executive Leadership Team 25

May 15, 2018: Intermountain Healthcare Appoints Rajesh Shrestha to Lead Community-Based Care 26

May 09, 2018: Gail Miller Chosen New Board Chair Of Intermountain Healthcare 27

Nov 02, 2017: Empiric Health Announces Justin Schaper as Chief Technology Officer to Advance Evidence-Based Technology Offering 28

Apr 05, 2017: Intermountain Healthcare Expands Its Top Leadership Team to Better Address Evolving Healthcare Challenges and Patient and Community Needs 29

Mar 01, 2017: Intermountain Healthcare Names Chief Patient Safety and Experience Officer 31

Feb 09, 2017: New Senior Vice President for Intermountain Medical Group and Medical Staff 32

Government and Public Interest 33

Oct 29, 2018: Intermountain Healthcare awarded USD 1 million grant by the National Institutes of Health 33

Sep 17, 2018: New coalition aims to improve US medical diagnoses quality 34

Sep 06, 2018: Three National Foundations Commit USD 30 Million to Civica Rx, a Groundbreaking Effort to Address Shortages and High Prices of Life-Saving Medications 35

Aug 16, 2018: There's no place like home: new study finds patients with low-risk blood clots may be better off receiving treatment at home 36

May 11, 2018: Study Finds New Combined Risk Score More Effectively Predicts Stroke Risk in Patients Who Have Atrial Fibrillation 38

Mar 10, 2018: Transcatheter Aortic Valve Replacement Dramatically Improves Heart Patients' Quality of Life, Study Finds 40

Jan 25, 2018: NCCN Imaging Appropriate Use Criteria Endorsed by Intermountain Healthcare and Will be Included in the Intermountain AUC for Lung Cancer 41

Jan 18, 2018: Trinity Health and Other Leading Health Systems Join Together to Develop a Not-for-profit Generic Drug Company 42

Jan 18, 2018: Ascension joins other leading U.S. health systems to develop not-for-profit generic drug company 44

Nov 20, 2017: NCCN, in Collaboration with Pfizer, Awards Nine Grants for Quality Improvement in Breast Cancer Care 46

Nov 13, 2017: Study Finds People with Certain Blood Types Have Increased Risks of Heart Attack During Periods of High Air Pollution 47

Oct 05, 2017: Intermountain Healthcare Announces an Additional USD 2 Million Donation to Fight Opioid Misuse 49

Oct 01, 2017: Pain management study designed to help patients reduce opioid use receives USD 8.8 million funding 50

Aug 30, 2017: USD 3.8 Million Awarded to Researchers at the University of Utah Health and Intermountain Healthcare 52

Aug 17, 2017: Six Research Teams Receive Intermountain-Stanford Grant Award 53

Jul 11, 2017: New Study Finds That Lymph Node Removal Isn't Necessary For All Melanoma Patients 54

Product News 56

Oct 08, 2017: Intermountain Researchers Launch Major Three-Year Genomics Breast Cancer Study 56

Jul 17, 2017: Intermountain Healthcare and Stanford University Use Precision Medicine Advances to Understand and Treat Cancer Cases 59

May 30, 2018: Intermountain, University of Michigan advance precision medicine for cardiovascular care, cancer 60

Apr 13, 2018: Intermountain Precision Genomics Announces PRECISE Study 61

Other Significant Developments 62

Oct 16, 2018: Intermountain Precision Genomics launches NGS ONE genomics services 62

Aug 15, 2018: Healthcare Innovators professional society reaches member goal of 33 top industry executives for nationwide council 63

Oct 17, 2017: Intermountain Healthcare Announces Precision Health Research Endeavors with 10x Genomics 64

May 23, 2017: Intermountain Healthcare Goes Live on the American Well Exchange 65

May 01, 2017: Intermountain Precision Genomics Announces Translational Science Center 66

Appendix 67

Methodology 67

About GlobalData 67

Contact Us 67

Disclaimer 67


List Of Figure

List of Figures

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Intermountain Healthcare Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Key Facts 2

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Intermountain Healthcare Inc, Deals By Therapy Area, 2012 to YTD 2018 9

Intermountain Healthcare Inc, Medical Devices Deals, 2012 to YTD 2018 10

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Tute Genomics Raises Additional USD3.9 Million in Series A1 Venture Financing 12

Ingram Medical Raises USD 30 Million In Series B Venture Financing 13

Seven Hospitals and Three Philanthropic Foundations Form Civica RX 14

Intermountain Healthcare Enters into Agreement with Stanford Genome Technology Center 16

Intermountain Healthcare Inc, Key Competitors 17

Intermountain Healthcare Inc, Key Employees 18

Intermountain Healthcare Inc, Other Locations 19

Intermountain Healthcare Inc, Subsidiaries 21

Intermountain Healthcare Inc, Joint Venture 21

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Summary

Intermountain Healthcare Inc (Intermountain Healthcare) is a non-profit health care system. It provides health care services to Utah and Southeastern Idaho residents. It offers a wide range of clinical programs covering cardiovascular, intensive medicine, primary care, pediatric specialties, surgical services, behavioral health, neurosciences, and musculoskeletal and its clinical services cover dialysis, environmental, food and nutrition, clinical genetics institute, imaging, integrated care management, laboratory, nursing, pain, patient and provider publications, patient flow, patient safety, pharmacy, rehabilitation, and respiratory care. Intermountain Healthcare operates through hospitals and clinics at various locations including Burley, Smithfield, Tremonton, Logan, Providence, Brigham City, Heber City, among several others. Intermountain is headquartered in Salt Lake City, Utah, the US.

Intermountain Healthcare Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Intermountain Healthcare Inc, Medical Devices Deals, 2012 to YTD 2018 10

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

Tute Genomics Raises Additional USD3.9 Million in Series A1 Venture Financing 12

Ingram Medical Raises USD 30 Million In Series B Venture Financing 13

Partnerships 14

Seven Hospitals and Three Philanthropic Foundations Form Civica RX 14

Intermountain Healthcare Enters into Agreement with Stanford Genome Technology Center 16

Intermountain Healthcare Inc-Key Competitors 17

Intermountain Healthcare Inc-Key Employees 18

Intermountain Healthcare Inc-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Joint Venture 21

Recent Developments 22

Strategy And Business Planning 22

Sep 20, 2018: New Intermountain Transformation Center to Lead Healthcare Delivery Advancement 22

Sep 06, 2018: Not-for-profit generic drug company officially established, attracts interest of more than 120 health organizations 23

Mar 01, 2018: Intermountain Healthcare Launches New Company, Expanding Access to Proven Mental Health Integration Approach 24

Corporate Communications 25

Aug 09, 2018: Intermountain Healthcare Names New Leaders to Executive Leadership Team 25

May 15, 2018: Intermountain Healthcare Appoints Rajesh Shrestha to Lead Community-Based Care 26

May 09, 2018: Gail Miller Chosen New Board Chair Of Intermountain Healthcare 27

Nov 02, 2017: Empiric Health Announces Justin Schaper as Chief Technology Officer to Advance Evidence-Based Technology Offering 28

Apr 05, 2017: Intermountain Healthcare Expands Its Top Leadership Team to Better Address Evolving Healthcare Challenges and Patient and Community Needs 29

Mar 01, 2017: Intermountain Healthcare Names Chief Patient Safety and Experience Officer 31

Feb 09, 2017: New Senior Vice President for Intermountain Medical Group and Medical Staff 32

Government and Public Interest 33

Oct 29, 2018: Intermountain Healthcare awarded USD 1 million grant by the National Institutes of Health 33

Sep 17, 2018: New coalition aims to improve US medical diagnoses quality 34

Sep 06, 2018: Three National Foundations Commit USD 30 Million to Civica Rx, a Groundbreaking Effort to Address Shortages and High Prices of Life-Saving Medications 35

Aug 16, 2018: There's no place like home: new study finds patients with low-risk blood clots may be better off receiving treatment at home 36

May 11, 2018: Study Finds New Combined Risk Score More Effectively Predicts Stroke Risk in Patients Who Have Atrial Fibrillation 38

Mar 10, 2018: Transcatheter Aortic Valve Replacement Dramatically Improves Heart Patients' Quality of Life, Study Finds 40

Jan 25, 2018: NCCN Imaging Appropriate Use Criteria Endorsed by Intermountain Healthcare and Will be Included in the Intermountain AUC for Lung Cancer 41

Jan 18, 2018: Trinity Health and Other Leading Health Systems Join Together to Develop a Not-for-profit Generic Drug Company 42

Jan 18, 2018: Ascension joins other leading U.S. health systems to develop not-for-profit generic drug company 44

Nov 20, 2017: NCCN, in Collaboration with Pfizer, Awards Nine Grants for Quality Improvement in Breast Cancer Care 46

Nov 13, 2017: Study Finds People with Certain Blood Types Have Increased Risks of Heart Attack During Periods of High Air Pollution 47

Oct 05, 2017: Intermountain Healthcare Announces an Additional USD 2 Million Donation to Fight Opioid Misuse 49

Oct 01, 2017: Pain management study designed to help patients reduce opioid use receives USD 8.8 million funding 50

Aug 30, 2017: USD 3.8 Million Awarded to Researchers at the University of Utah Health and Intermountain Healthcare 52

Aug 17, 2017: Six Research Teams Receive Intermountain-Stanford Grant Award 53

Jul 11, 2017: New Study Finds That Lymph Node Removal Isn't Necessary For All Melanoma Patients 54

Product News 56

Oct 08, 2017: Intermountain Researchers Launch Major Three-Year Genomics Breast Cancer Study 56

Jul 17, 2017: Intermountain Healthcare and Stanford University Use Precision Medicine Advances to Understand and Treat Cancer Cases 59

May 30, 2018: Intermountain, University of Michigan advance precision medicine for cardiovascular care, cancer 60

Apr 13, 2018: Intermountain Precision Genomics Announces PRECISE Study 61

Other Significant Developments 62

Oct 16, 2018: Intermountain Precision Genomics launches NGS ONE genomics services 62

Aug 15, 2018: Healthcare Innovators professional society reaches member goal of 33 top industry executives for nationwide council 63

Oct 17, 2017: Intermountain Healthcare Announces Precision Health Research Endeavors with 10x Genomics 64

May 23, 2017: Intermountain Healthcare Goes Live on the American Well Exchange 65

May 01, 2017: Intermountain Precision Genomics Announces Translational Science Center 66

Appendix 67

Methodology 67

About GlobalData 67

Contact Us 67

Disclaimer 67


List Of Figure

List of Figures

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Intermountain Healthcare Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Key Facts 2

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Intermountain Healthcare Inc, Deals By Therapy Area, 2012 to YTD 2018 9

Intermountain Healthcare Inc, Medical Devices Deals, 2012 to YTD 2018 10

Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Tute Genomics Raises Additional USD3.9 Million in Series A1 Venture Financing 12

Ingram Medical Raises USD 30 Million In Series B Venture Financing 13

Seven Hospitals and Three Philanthropic Foundations Form Civica RX 14

Intermountain Healthcare Enters into Agreement with Stanford Genome Technology Center 16

Intermountain Healthcare Inc, Key Competitors 17

Intermountain Healthcare Inc, Key Employees 18

Intermountain Healthcare Inc, Other Locations 19

Intermountain Healthcare Inc, Subsidiaries 21

Intermountain Healthcare Inc, Joint Venture 21

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS